Watchlist Price Alert

Fennec Pharmaceuticals In... (FENC)

NASDAQ: FENC · Real-Time Price · USD

5.96

-0.25 (-3.95%)

At close: May 09, 2025, 3:59 PM

5.67

-4.87%

After-hours: May 09, 2025, 04:21 PM EDT

-3.95% (1D)

Bid	5.38
Market Cap	164.48M
Revenue (ttm)	47.54M
Net Income (ttm)	-70K
EPS (ttm)	-0.02
PE Ratio (ttm)	-298
Forward PE	5.94
Analyst	Buy

Ask	6.59
Volume	37,198
Avg. Volume (20D)	82,126
Open	6.20
Previous Close	6.21
Day's Range	5.92 - 6.18
52-Week Range	3.96 - 10.07
Beta	0.32

About FENC

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol FENC

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for FENC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Fennec Pharmaceuticals Inc. is scheduled to release its earnings on May 13, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

-11.19%

Fennec Pharmaceuticals shares are trading lower af... Unlock content with Pro Subscription

6 months ago

-11.92%

Fennec Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q3 financial results.

News

1 week ago · zacks.com

Wall Street Analysts See an 113.25% Upside in Adherex Technologies (FENC): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 113.3% in Adherex Technologies (FENC). While the effectiveness of this highly sought-after metric is questionab...

1 month ago · zacks.com

Down -22.15% in 4 Weeks, Here's Why Adherex Technologies (FENC) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Adherex Technologies (FENC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Stree...

2 months ago · seekingalpha.com

Fennec Pharmaceuticals Inc. (FENC) Q4 2024 Earnings Call Transcript

Fennec Pharmaceuticals Inc. (NASDAQ:FENC ) Q4 2024 Earnings Conference Call March 10, 2025 8:30 AM ET Company Participants Robert Andrade - CFO Jeff Hackman - CEO and Board Member Conference Call Part...

2 months ago · zacks.com

Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates

Adherex Technologies Inc. (FENC) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.56. This compares to loss of $0.10 per share a year ago.